Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Immunotherapy for mesothelioma could be on the horizon

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.06.17
Views: 1222

Dr Arnaud Scherpereel - University Hospital of Lille, Lille, France

Dr Scherpereel presents, at a press conference at ASCO 2017, early findings from his ongoing phase II clinical trial in France, MAPS-2, showing that immunotherapy may slow the growth of malignant pleural mesothelioma after relapse.

Read the news story for more. 


Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation